Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “LTD.”

1,301 pharma patents match "LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,301
Index total 30,257
Page 36 / 55

Quick answer

This filtered view shows 1,301 pharmaceutical patents matching "LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,301 results for “LTD.” · 30,257 patents in full index Clear search

  1. US 7598420

    Rasagiline formulations and processes for their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 6, 2009 · Expires Oct 1, 2029

    granted
  2. US 7589075

    Use of an adenosine A3 receptor agonist for inhibition of viral replication

    CAN-FITE BIOPHARMA LTD. · Granted Sep 15, 2009 · Expires Sep 10, 2029

    granted
  3. US 7582759

    Diastereomeric purification of rosuvastatin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Sep 1, 2009 · Expires Aug 27, 2029

    granted
  4. US 7579333

    Therapy using a combination of raloxifene and alendronate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 25, 2009 · Expires Aug 20, 2029

    granted
  5. US 7572834

    Rasagiline formulations and processes for their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 11, 2009 · Expires Aug 6, 2029

    granted
  6. US 7572641

    Pharmaceutical compositions comprising meloxicam and methods of their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 11, 2009 · Expires Aug 6, 2029

    granted
  7. US 7563918

    Solid and crystalline ibandronate sodium and processes for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 21, 2009 · Expires Jul 16, 2029

    granted
  8. US 7563930

    Crystal forms of Cinacalcet HCI and processes for their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 21, 2009 · Expires Jul 16, 2029

    granted
  9. US 7547806

    Tannate salt of rasagiline

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted
  10. US 7547787

    Processes for preparing montelukast sodium

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted
  11. US 7538136

    Crystalline forms of atorvastatin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 26, 2009 · Expires May 21, 2029

    granted
  12. US 7534913

    Crystalline form of nateglinide

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 19, 2009 · Expires May 14, 2029

    granted
  13. US 7534900

    Process for the purification of duloxetine hydrochloride

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 19, 2009 · Expires May 14, 2029

    granted
  14. US 7514467

    Crystalline solids of carvedilol and processes for their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 7, 2009 · Expires Apr 2, 2029

    granted
  15. US 7511174

    Solid and crystalline ibandronic acid

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted
  16. US 7507753

    Biaryl compound and use thereof

    Takeda Chemical Industries Ltd. · Granted Mar 24, 2009 · Expires Mar 19, 2029

    granted
  17. US 7507829

    Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 24, 2009 · Expires Mar 19, 2029

    granted
  18. US 7504504

    Methods of preparing aripiprazole crystalline forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 17, 2009 · Expires Mar 12, 2029

    granted
  19. US 7501448

    Process for preparing telmisartan

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 10, 2009 · Expires Mar 5, 2029

    granted
  20. US 7501450

    Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 10, 2009 · Expires Mar 5, 2029

    granted
  21. US 7495072

    Process for preparation of mixtures of polypeptides using purified hydrobromic acid

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 24, 2009 · Expires Feb 19, 2029

    granted
  22. US 7491847

    Methods for isolating propargylated aminoindans

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 17, 2009 · Expires Feb 12, 2029

    granted
  23. US 7488750

    Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 10, 2009 · Expires Feb 5, 2029

    granted
  24. US 7485663

    Carvedilol

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted